chymotrypsin/neoplasms

FIELD OF THE INVENTION The present invention relates to polyphenol esters derived from green and black teas, and analogs thereof, which are potent inhibitors of the growth of cancerous cells. Specifically, the invention relates to polyphenol esters that inhibit chymotrypsin-like, but not

The present invention relates to purified nucleic acids encoding a krill-derived enzymes such as proteinases, which can be a multifunctional protein, and to purified polypeptides. A protein having "multifunctional activity," is defined herein as including at least one of a chymotrypsin, trypsin,

The present invention relates to purified nucleic acids encoding a krill-derived multifunctional protein and to purified polypeptides having multifunctional activity. A protein having "multifunctional activity," is defined herein as including at least one of a chymotrypsin, trypsin, collagenase,

The present invention relates to a krill-derived multifunctional enzyme and a family of crustacean and fish derived enzymes having substantial structural similarity to the multifunctional enzyme derived from antarctic krill. The invention additionally relates to the multifunctional enzyme, to

The present invention relates to the discovery that there exists a family of crustacean and fish derived enzymes having substantial structural similarity to an enzyme derived from antarctic krill. The krill enzyme is the subject of U.S. patent application Ser. No. 08/338,501, filed Nov. 22, 1994,

TECHNICAL FIELD This invention generally relates to drug discovery, medicine and cell biology. In particular, in alternative embodiments, the invention provides pharmaceutical compounds and formulations comprising a family of epoxyketone compounds, which include racemic mixtures or racemates,

BACKGROUND OF THE INVENTION I. Field of the Invention The present invention relates to a monoclonal antibodies useful for diagnosing cancers, inflammation and Alzheimer's disease and hybridomas producing the same. The present invention also relates to human .alpha..sub.1 -antichymotrypsin and

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to a human monocyte growth factor for stimulating differentiation and proliferation of human peripheral blood monocyte, and a purification process for purifying the growth factor. The hematopoietic progenitor cell is

The present invention relates to a krill-derived multifunctional enzyme and a family of crustacean and fish derived enzymes having substantial structural similarity to the multifunctional enzyme derived from antarctic krill. The invention additionally relates to the multifunctional enzyme, to

The present invention relates to a krill-derived multifunctional enzyme and a family of crustacean and fish derived enzymes having substantial structural similarity to the multifunctional enzyme derived from antarctic krill. The invention additionally relates to the multifunctional enzyme, to

The following examples illustrate the present invention, but it is to be understood that they are given for the purpose of illustration and not limitation. EXAMPLE 1 A medium (100 l) containing 6.0% soluble starch, 4.0% cotton seed meal, 0.2% (NH.sub.4).sub.2 SO.sub.4, 0.1% yeast extract, 0.2%

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel class of peptidyl derivatives of aromatic diesters of .alpha.-aminoalkylphosphonic acids useful for selectively inhibiting elastase, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting